Gilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MOREUse SHUTOUT® teat sealant to create a physical barrier against mastitis-causing environmental bacteria in dry dairy cows.
LEARN MOREFor treatment of respiratory disease associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Salmonella Choleraesuis, Streptococcus…
LEARN MOREFor treatment of BRD associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and bovine interdigital phlegmon associated with…
LEARN MORE